Physician profile
Jay Acharya
NPI 1871995498
$127,920.13
in general payments reported to CMS, 2019-2025
10 companies · $4,969 in 2025
The $4,969 reported for 2025 was more than what 82% of Neuroradiology providers received nationally (typical 2025 total: $278).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $14K · 2021: $5,776 · 2022: $25K · 2023: $50K · 2024: $18K · 2025: $4,969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $62K · Travel and Lodging: $7,286 · Food and Beverage: $3,383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $62,312.50 |
| Travel and Lodging | $7,286.11 |
| Food and Beverage | $3,383.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $85,572.28 | 2019-2025 | Autoplex, Optablate, Spinejack |
| Medtronic USA, INC. | $13,897.81 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $10,723.78 | 2024-2025 | Trek |
| Siemens Medical Solutions USA, INC. | $10,243.09 | 2019-2021 | |
| Medtronic, INC. | $5,869.48 | 2021-2024 | Synchromedii |
| Boston Scientific Corporation | $1,228.40 | 2024-2025 | Intracept |
| Icotec Medical INC. | $187.49 | 2024 | Icotec Blackarmor Spine System |
| Nevro Corp. | $128.00 | 2024 | Senza |
| Angiodynamics, INC. | $47.10 | 2025 | Alphavac |
| Biogen, INC. | $22.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Acharya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.